Literature DB >> 7943484

HIV infection among women in prison: an assessment of risk factors using a nonnominal methodology.

C A Hankins1, S Gendron, M A Handley, C Richard, M T Tung, M O'Shaughnessy.   

Abstract

The relative contributions of needle use practices and sexual behaviors to human immunodeficiency virus (HIV) antibody seropositivity among 394 women incarcerated in Quebec were determined by risk factor assessment and serology with a nonnominal methodology. HIV positivity was found in 6.9% (95% confidence interval [CI] = 4.6, 9.9) of all participants and in 13% (95% CI = 8.6, 18.6) of women with a history of injection drug use. HIV seropositivity among women with a history of injection drug use was predicted by sexual or needle contact with a seropositive person, self-reported genital herpes, and having had a regular sexual partner who injected drugs, but it was not predicted by prostitution. Nonnominal testing is an ethical alternative to mandatory and anonymous unlinked testing among correctional populations.

Entities:  

Mesh:

Year:  1994        PMID: 7943484      PMCID: PMC1615080          DOI: 10.2105/ajph.84.10.1637

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  9 in total

Review 1.  AIDS in prison: a review of epidemiology and preventive policy.

Authors:  T F Brewer; J Derrickson
Journal:  AIDS       Date:  1992-07       Impact factor: 4.177

2.  On research on HIV infection and AIDS in correctional institutions.

Authors:  N N Dubler; V W Sidel
Journal:  Milbank Q       Date:  1989       Impact factor: 4.911

Review 3.  Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases.

Authors:  J N Wasserheit
Journal:  Sex Transm Dis       Date:  1992 Mar-Apr       Impact factor: 2.830

4.  HIV testing in prisoners: is mandatory testing mandatory?

Authors:  J K Andrus; D W Fleming; C Knox; R O McAlister; M R Skeels; R E Conrad; J M Horan; L R Foster
Journal:  Am J Public Health       Date:  1989-07       Impact factor: 9.308

5.  HIV infection among women entering the New York State correctional system.

Authors:  P F Smith; J Mikl; B I Truman; L Lessner; J S Lehman; R W Stevens; E A Lord; R K Broaddus; D L Morse
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

6.  HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin.

Authors:  N J Hoxie; J M Vergeront; H R Frisby; J R Pfister; R Golubjatnikov; J P Davis
Journal:  Am J Public Health       Date:  1990-09       Impact factor: 9.308

7.  Sentinel surveillance of HIV infection among new inmates and implications for policies of corrections facilities.

Authors:  K K Patel; C Hutchinson; D G Sienko
Journal:  Public Health Rep       Date:  1990 Sep-Oct       Impact factor: 2.792

8.  Anonymous HIV surveillance in Saughton Prison, Edinburgh.

Authors:  A G Bird; S M Gore; D W Jolliffe; S M Burns
Journal:  AIDS       Date:  1992-07       Impact factor: 4.177

9.  Prevalence of antibody to HIV-1 among entrants to US correctional facilities.

Authors:  D Vlahov; T F Brewer; K G Castro; J P Narkunas; M E Salive; J Ullrich; A Muñoz
Journal:  JAMA       Date:  1991-03-06       Impact factor: 56.272

  9 in total
  14 in total

Review 1.  The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis.

Authors:  Princess A Iroh; Helen Mayo; Ank E Nijhawan
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

2.  The British Columbia Positive Women's Survey: a detailed profile of 110 HIV-infected women.

Authors:  C M Kirkham; D J Lobb
Journal:  CMAJ       Date:  1998-02-10       Impact factor: 8.262

3.  Parole officer-parolee relationships and HIV risk behaviors during community supervision.

Authors:  Traci C Green; Jennifer Johnson; Magdalena Harrington; Enrique R Pouget; Anne G Rhodes; Faye S Taxman; Daniel J O'Connell; Steven S Martin; Michael Prendergast; Peter D Friedmann
Journal:  AIDS Behav       Date:  2013-10

4.  Risky relationships: targeting HIV prevention for women offenders.

Authors:  Carl Leukefeld; Jennifer Havens; Michele Staton Tindall; Carrie B Oser; Jennifer Mooney; Martin T Hall; Hannah K Knudsen
Journal:  AIDS Educ Prev       Date:  2012-08

5.  Recent incarceration independently associated with syringe sharing by injection drug users.

Authors:  Evan Wood; Kathy Li; Will Small; Julio S Montaner; Martin T Schechter; Thomas Kerr
Journal:  Public Health Rep       Date:  2005 Mar-Apr       Impact factor: 2.792

6.  Relationship influence and health risk behavior among re-entering women offenders.

Authors:  Michele Staton-Tindall; Linda Frisman; Hsui-Ju Lin; Carl Leukefeld; Carrie Oser; Jennifer R Havens; Michael Prendergast; Hilary L Surratt; Jennifer Clarke
Journal:  Womens Health Issues       Date:  2011-02-11

7.  Partner relationships and HIV risk behaviors among women offenders.

Authors:  Hannah K Knudsen; Carl Leukefeld; Jennifer R Havens; Jamieson L Duvall; Carrie B Oser; Michele Staton-Tindall; Jennifer Mooney; Jennifer G Clarke; Linda Frisman; Hilary L Surratt; James A Inciardi
Journal:  J Psychoactive Drugs       Date:  2008-12

8.  Examination of an interventionist-led HIV intervention among criminal justice-involved female prisoners.

Authors:  Jennifer R Havens; Carl G Leukefeld; Carrie B Oser; Michele Staton-Tindall; Hannah K Knudsen; Jennifer Mooney; Jamieson L Duvall; Jennifer G Clarke; Linda Frisman; Hilary L Surratt; James A Inciardi
Journal:  J Exp Criminol       Date:  2009-09-01

9.  Predictive factors of HIV-infection in injecting drug users upon incarceration.

Authors:  V Martín; J A Caylà; M L Morís; L E Alonso; R Pérez
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

10.  Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities.

Authors:  Liviana Calzavara; Nancy Ramuscak; Ann N Burchell; Carol Swantee; Ted Myers; Peter Ford; Margaret Fearon; Sue Raymond
Journal:  CMAJ       Date:  2007-07-31       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.